Capítulo de Libro

Drug Metabolism Functionalization (Phase I) Reactions

Talevi, Alan Icon; Bellera, Carolina Leticia Icon

Otros responsables

Fecha

2021

Editorial

Springer Nature Switzerland AG

Revista

Título del libro

The ADME Encyclopedia

Nombre del evento

Fecha del evento

Institución organizadora

ISSN

eISSN

ISBN

978-3-030-51519-5

Idioma

Inglés

Tipo del evento

Clasificación temática

Resumen

Functionalization (or Phase I) reactions of drug metabolism are those that introduce a functional drug to their substrates (for instance, in hydroxylation) or modify an existing one (e.g., in hydrolysis). The term functionalization is sometimes preferred to Williams’ classic Phase I denomination. Williams’ nomenclature reflects the usual scheme of sequential metabolism, where the parent drug is converted to a primary, or first-generation, metabolite, which in turn is subjected to a second biotransformation reaction that yields a secondary, or second-generation, metabolite. Whereas it is true that functionalization reactions often “prepare” their substrate to undergo a conjugation (Phase II) reaction (because they provide the substrate with a chemical “anchor” site for a conjugation to occur, such as a -OH or a -NH function), there are many deviations from this too general scheme. For instance, many Phase I metabolites are excreted without experiencing Phase II reactions. Similarly, the intact drug may directly undergo a Phase II transformation without a previous Phase I reaction. A drug may undergo one or more subsequent Phase I reactions before being conjugated (see Fig. 1 for figures). Finally, drug metabolism tends to operate in parallel and not only serially, since many different biotransformations occur simultaneously to different drug molecules of the same compound.

Aprobación

Revisión

Complementado por

Referenciado por

Licencia Creative Commons

Excepto donde se indique lo contrario, la licencia de este ítem se describe como by-nc-sa